1. |
Thuong NTT, Heemskerk D, Tram TTB, et al. Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis. J Infect Dis, 2017, 215(7): 1020-1028.
|
2. |
Thwaites GE, van Toorn R, Schoeman J, et al. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol, 2013, 12(10): 999-1010.
|
3. |
Heemskerk AD, Bang ND, Mai NT, et al. Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med, 2016, 374(2): 124-134.
|
4. |
Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004, 351(17): 1741-1751.
|
5. |
Brancusi F, Farrar J, Heemskerk D, et al. Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol, 2012, 7(9): 1101-1116.
|
6. |
Marais S, Thwaites GE, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010, 10(11): 803-812.
|
7. |
Marais BJ, Heemskerk AD, Marais SS, et al. Standardized methods for enhanced quality and comparability of tuberculous meningitis studies. Clin Infect Dis, 2016, 64(4): 501-509.
|
8. |
Streptomycin in Tuberculosis Trials Commitee, Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet, 1948, 1(6503): 582-596.
|
9. |
Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect, 2009, 59(3): 167-187.
|
10. |
Quinn TJ, Dawson J, Walters MR, et al. Reliability of the modified rankin scale: a systematic review. Stroke, 2009, 40(10): 3393-3395.
|
11. |
Hsu PC, Yang CC, Ye JJ, et al. Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in Northern Taiwan. J Microbiol Immunol Infect, 2010, 43(2): 111-118.
|
12. |
Li K, Tang H, Yang Y, et al. Clinical features, long-term clinical outcomes, and prognostic factors of tuberculous meningitis in West China: a multivariate analysis of 154 adults. Expert Rev Anti Infect Ther, 2017, 15(6): 629-635.
|
13. |
Jha SK, Garg RK, Jain A, et al. Definite (microbiologically confirmed) tuberculous meningitis: predictors and prognostic impact. Infection, 2015, 43(6): 639-645.
|
14. |
George EL, Iype T, Cherian A, et al. Predictors of mortality in patients with meningeal tuberculosis. Neurol India, 2012, 60(1): 18-22.
|
15. |
Huang HJ, Ren ZZ, Dai YN, et al. Old age and hydrocephalus are associated with poor prognosis in patients with tuberculous meningitis: a retrospective study in a Chinese adult population. Medicine (Baltimore), 2017, 96(26): e7370.
|
16. |
Gu J, Xiao H, Wu F, et al. Prognostic factors of tuberculous meningitis: a single-center study. Int J Clin Exp Med, 2015, 8(3): 4487-4493.
|
17. |
Wasay M, Farooq S, Khowaja ZA, et al. Cerebral infarction and tuberculoma in central nervous system tuberculosis: frequency and prognostic implications. J Neurol Neurosurg Psychiatry, 2014, 85(11): 1260-1264.
|
18. |
Kaur H, Sharma K, Modi M, et al. Prospective analysis of 55 cases of tuberculosis meningitis (TBM) in North India. J Clin Diagn Res, 2015, 9(1): DC 15-19.
|
19. |
Merkler AE, Reynolds AS, Gialdini G, et al. Neurological complications after tuberculous meningitis in a multi-state cohort in the United States. J Neurol Sci, 2017, 375: 460-463.
|
20. |
Wasay M, Khan M, Farooq S, et al. Frequency and impact of cerebral infarctions in patients with tuberculous meningitis. Stroke, 2018, 49(10): 2288-2293.
|
21. |
Be NA, Kim KS, Bishai WR, et al. Pathogenesis of central nervous system tuberculosis. Curr Mol Med, 2009, 9(2): 94-99.
|
22. |
Mezochow A, Thakur K, Vinnard C, et al. Tuberculous meningitis in children and adults: new insights for an ancient foe. Curr Neurol Neurosci Rep, 2017, 17(11): 85.
|
23. |
Modi M, Sharma K, Prabhakar S, et al. Clinical and radiological predictors of outcome in tubercular meningitis: a prospective study of 209 patients. Clin Neurol Neurosurg, 2017, 161: 29-34.
|
24. |
Majeed S, Singh P, Sharma N, et al. Role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease. BMC Infect Dis, 2016, 16(1): 722.
|
25. |
Kalita J, Misra UK, Ranjan P, et al. Predictors of long-term neurological sequelae of tuberculous meningitis: a multivariate analysis. Eur J Neurol, 2007, 14(1): 33-37.
|
26. |
Raut T, Garg RK, Jain A, et al. Hydrocephalus in tuberculous meningitis: incidence, its predictive factors and impact on the prognosis. J Infect, 2013, 66(4): 330-337.
|
27. |
Donald PR, Van Toorn R. Use of corticosteroids in tuberculous meningitis. Lancet, 2016, 387(10038): 2585-2587.
|
28. |
Sharma P, Garg RK, Verma R, et al. Incidence, predictors and prognostic value of cranial nerve involvement in patients with tuberculous meningitis: a retrospective evaluation. Eur J Intern Med, 2011, 22(3): 289-295.
|